ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38596115

CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B.

Song J and 9 others. Heliyon, 2024. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B. Papers, record 38596115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38596115

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CCL20 and CD8A as potential diagnostic biomarkers for HBV-induced liver fibrosis in chronic hepatitis B.
PubMed
Journal
Heliyon
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.12, provisional
iCite
Revised in PubMed
2024-04-11
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song JJingru
2Liu LLu
3Wang ZZheng
4Xie DDong
5Azami NLBNisma Lena Bahaji
6Lu LLu
7Huang YYanping
8Ye WWei
9Zhang QQin
10Sun MMingyu

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,640,800CD8A gene polymorphisms predict severity factors in chronic rhinosinusitis.Int Forum Allergy Rhinol2013https://conductscience.org/library/papers/23640800PubMed
228,545,106Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.PLoS One2017https://conductscience.org/library/papers/28545106PubMed
324,675,400Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming.Nat Commun2014https://conductscience.org/library/papers/24675400PubMed
428,624,924Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.Abdom Radiol (NY)2017https://conductscience.org/library/papers/28624924PubMed
530,992,636Countdown to 2030: eliminating hepatitis B disease, China.Bull World Health Organ2019https://conductscience.org/library/papers/30992636PubMed
632,086,762Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging.Mol Imaging Biol2020https://conductscience.org/library/papers/32086762PubMed
724,875,649Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.Int J Biochem Cell Biol2014https://conductscience.org/library/papers/24875649PubMed
826,206,574Reversibility of liver fibrosis.Clin Res Hepatol Gastroenterol2015https://conductscience.org/library/papers/26206574PubMed
926,231,459Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Lancet2015https://conductscience.org/library/papers/26231459PubMed
1012,591,185Liver fibrosis -- from bench to bedside.J Hepatol2003https://conductscience.org/library/papers/12591185PubMed

1 to 10 of 62

See all 62 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42,548,584CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis.Front Immunol2026https://conductscience.org/library/papers/42548584PubMed
41,791,704Targeting the Golgi apparatus enhances PD-L1 blockade and synergizes with oxaliplatin to improve immunotherapy efficacy.J Biol Chem2026https://conductscience.org/library/papers/41791704PubMed
41,586,310Liver fibrosis and cirrhosis in the multi-omics era: mechanisms and therapeutic perspectives from human and animal models.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41586310PubMed
41,178,887Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B.World J Gastrointest Surg2025https://conductscience.org/library/papers/41178887PubMed
41,157,623Association Between Serum HBV DNA Levels and CCL-20, CD8a, CXCL-16, and GDF-15 in Patients with Chronic Hepatitis B.Viruses2025https://conductscience.org/library/papers/41157623PubMed
39,075,660Comprehensive immune modulation mechanisms of Angong Niuhuang Wan in ischemic stroke: Insights from mass cytometry analysis.CNS Neurosci Ther2024https://conductscience.org/library/papers/39075660PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL206,364PubTator's text mininghttps://conductscience.org/library/genes/6364NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38596115

GET https://conductscience.org/api/papers/v1/38596115/references?page=2

API referenceFor AI assistants